pharmaphorum14d
GSK's Nucala gains US use in rare autoimmune disease
GlaxoSmithKline’s Nucala (mepolizumab) has gained a new FDA approval for the rare autoimmune disease eosinophilic granulomatosis with polyangiitis (EGPA). Nucala, an interleukin-5 (IL-5 ...
Yahoo Finance20d
China’s NMPA approves GSK’s Nucala for CRSwNP treatment
The China National Medical Products Administration (NMPA) has approved GSK’s Nucala (mepolizumab) as an add-on treatment with intranasal corticosteroids to treat chronic rhinosinusitis with ...
BioPharma Dive20d
Navigating future biopharma catalysts: What to expect at the 2025 J.P. Morgan Healthcare Conference
While many presentation topics are not disclosed prior to the event, one anticipated highlight is from Anavex Life Sciences Corp (NASDAQ: AVXL), who is set to present Phase 2/3 data of blarcamesine ...
Pharmabiz22d
GSK receives China NMPA approval for Nucala to treat adults with chronic rhinosinusitis with nasal polyps
GSK plc announced that the China National Medical Products Administration (NMPA) has approved Nucala (mepolizumab), a monoclonal antibody that targets interleukin-5 (IL-5), as an add-on therapy with ...
Yahoo Finance22d
GSK’s Nucala Gains Approval in China for CRSwNP
GSK announced that its monoclonal antibody, Nucala (mepolizumab), has been approved in China for treating adults with chronic rhinosinusitis with nasal polyps (CRSwNP), a condition affecting 30 ...
ENDPOINTS NEWS23d
GSK’s Nu­cala bags an­oth­er Chi­na ap­proval, but biggest test yet to come
GSK’s block­buster res­pi­ra­to­ry drug Nu­cala has se­cured a Chi­na la­bel ex­pan­sion for cer­tain pa­tients with in­flamed si­nus­es. But a more im­por­tant chal­lenge on ...
ENDPOINTS NEWS23d
Af­ter Ca­griSe­ma, eyes are on Lil­ly’s oral GLP-1 as next key obe­si­ty play
With the dis­ap­point­ment of No­vo Nordisk’s in­ject­ed Ca­griSe­ma in obe­si­ty at the end of 2024, ...
Nasdaq23d
GSK’s Nucala Gains Approval in China for CRSwNP
Nucala (mepolizumab), has been approved in China for treating adults with chronic rhinosinusitis with nasal polyps (CRSwNP), a condition affecting 30 million people in the country. This approval ...
The Pharma Letter23d
GSK’s Nucala wins wider approval in China
China’s National Medical Products Administration (NMPA) has approved Nucala (mepolizumab), a monoclonal antibody from UK pharma major GSK (LSE: GSK) that targets interleukin-5 (IL-5). The new ...
Pharmaceutical Technology23d
From Davids to Goliaths: the GLP-1RA gold rush
VK-2735 may be the first oral GLP-1R to gain approval in obesity. Credit: zimmytws via Shutterstock. Drugs targeting the glucagon-like peptide-1 receptor (GLP-1R) demonstrated remarkable success in ...
Search Engine Land24d
Google Ads plans major AI Push in 2025, reshaping search marketing
Search Engine Land » PPC » Google Ads plans major AI Push in 2025, reshaping search marketing Chat with SearchBot Please note that your conversations will be recorded. Google Ads is preparing ...